In this subanalysis of data from the ADjoin trial of lebrikizumab, the interleukin-13 receptor inhibitor that is also a ...

Residents in historically redlined grade D areas were 1.67 times more likely to have no rapid access to EMS than in grade A ...

Adults with type 2 diabetes, especially those in vulnerable groups, face higher risks of medical debt, low credit scores, and ...

Amy Paller, MD, pediatric dermatologist and clinical researcher at Northwestern Medicine's Feinberg School of Medicine, ...

Experts highlight advances in therapies, research on skin of color, and the impact of social determinants of health at the ...

Despite their devastating global impact, chronic respiratory diseases remain a hidden threat in low- and middle-income ...

Vivek Bhalla, MD, Stanford, calls for greater awareness and implementation of existing screening guidelines to help identify patients who may benefit from more targeted, disease-specific interventions ...

Panelists discuss how recent updates from the phase 3 IsKia trial demonstrate that isatuximab combined with carfilzomib, lenalidomide, and dexamethasone improves minimal residual disease negativity ...

Panelists discuss how the PERSEUS trial’s subgroup analysis reinforced that sustained minimal residual disease negativity predicts better long-term outcomes and demonstrated the potential for ...

An inverse association between Alzheimer disease special care units in nursing homes and the percentage of Black residents within a facility was seen in a new study, but states with higher Medicaid ...

In this retrospective study, Rakendu Rajendran, MBBS, and colleagues found higher rates of myocardial infarction and major adverse cardiovascular events in males and increased stroke incidence in ...

Digital patient profiles and expansive real-world data are reshaping oncology clinical trials, explained Gen Li, PhD, MBA, ...